Zdrowie i gospodarka · 05/05/2010
FDA Withdraws BREVIBLOC (Esmolol Hydrochloride) Injection from Sale Due to Safety Concerns
The FDA has determined that BREVIBLOC (esmolol hydrochloride) injection, 250 milligrams per milliliter, was withdrawn from sale due to safety concerns, and the agency will no longer accept new drug applications for this product.